Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry

Journal of Lipid Research

Volumn 45, Issue 4, 2004, Pages 757-763

  Weber, Allan ^a   Ni, Jinsong ^a   Ling, Kah Hiing John ^a   Acheampong, Andrew ^a   Tang Liu, Diane D S ^a   Burk, Robert ^a   Cravatt, Benjamin F ^b   Woodward, David ^a  

^a ALLERGAN INC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Anandamide; Cyclooxygenase 2; Fatty acid amide hydrolase; High performance liquid chromatography; PGD2 1 ethanolamide; PGE2 1 ethanolamide; PGF2 1 ethanolamide; Prostamide D2

Indexed keywords

ANANDAMIDE; CYCLOOXYGENASE 2; ETHANOLAMINE DERIVATIVE; FATTY ACID AMIDASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAMIDE; PROSTAMIDE D2; PROSTAMIDE E2; PROSTAMIDE F2ALPHA; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KIDNEY; KNOCKOUT MOUSE; LIQUID LIQUID EXTRACTION; LIVER; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; TANDEM MASS SPECTROMETRY;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; DINOPROSTONE; INTESTINE, SMALL; ISOENZYMES; KIDNEY; LIVER; LUNG; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; POLYUNSATURATED ALKAMIDES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; TISSUE DISTRIBUTION;

EID: 1642547042     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300475-JLR200     Document Type: Article

References (24)

1. Bisogno, T., S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo. 1997. Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem. 272: 3315-3323.
2. Sugiura, T., S. Konko, A. Sukagawa, T. Tonegawa, S. Nakane, A. Yamashita, and K. Waku. 1996. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca2+-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun. 218: 113-117.
3. Smith, P. B., D. R. Compton, S. P. Welch, R. K. Razdan, R. Mechoulam, and B. R. Martin. 1994. The pharmacological activity of anandamide, a putative endogenous cannabinoid in mice. J. Pharmacol. Exp. Therap. 270: 219-227.
4. Rodriguez de Fonseca, F., I. Del Arco, J. L. Martin-Calderon, M. A. Gorriti, and M. Navarro. 1998. Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol. Dis. 5: 483-501.
5. Chakrabarti, A., J. E. Ekuta, and E. S. Onaivi. 1998. Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res. Bull. 45: 67-74.
6. Watanabe, K., T. Matsunaga, S. Nakamura, T. Kimura, I. K. Ho, H. Yoshimura, and I. Yamamoto. 1999. Pharmacological effects in mice of anandamide and its related fatty acid acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride. Bio. Pharm. Bull. 22: 366-370.
7. Cravatt, B. F., D. K. Giang, S. P. Mayfield, D. L. Boger, R. A. Lerner, and N. B. Gilula. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384: 83-87.
8. Giang, D. K., and B. F. Cravat. 1997. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA. 94: 2238-2242.
9. Willoughby, K. A., S. F. Moore, B. R. Martin, and E. F. Ellis. 1997. The biodisposition and metabolism of anandamide in mice. J. Pharmacol. Exp. Ther. 282: 243-247.
10. Yu, M., D. Ives, and C. S. Ramesha. 1997. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem. 272: 21181-21186.
11. Burstein, S. H., R. G. Rossetti, B. Yagen, and R. B. Zurier. 2000. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 61: 29-41.
12. Marnett, L. J., S. W. Rowlinson, D. C. Goodwin, A. S. Kalgutkar, and C. A. Lanzo. 1999. Arachidonic acid oxygenation by COX-1 and COX-2. J. Biol. Chem. 274: 22903-22906.
13. 2α with a hydroxyl or methoxy substituent provides biologically unique compounds. Br. J. Pharmacol. 130: 1933-1943.
14. Woodward, D. F., A. H-P. Krauss, J. Chen, R. K. Lai, C. S. Spada, R. M. Burk, S. W. Andrews, L. Shi, Y. Liang, K. M. Kedzie, R. Chen, D. W. Gil, A. Kharlamb, A. Acheampong, J. Ling, C. Madhu, J. Ni, P. Rix, J. Usansky, H. Usansky, A. Weber, D. Welty, W. Yang, D. D-S. Tang-Liu, M. E. Garst, B. Brar, L. A. Wheeler, and L. J. Kaplan. 2001. Pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol. 45 (Suppl. 4): S337-S345.
15. Kozak, K. R., B. C. Crews, J. L. Ray, H. H. Tai, J. D. Morrow, and L. J. Marnett. 2001. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J. Biol. Chem. 276: 36993-36998.
16. Zimmerman, K. C., M. Sarbia, K. Schror, and A. A. Weber. 1998. Constitutive cyclooxygenase expression in healthy humans and rabbit gastric mucosa. Mol. Pharmacol. 54: 536-540.
17. Nantel, F., E. Meadows, D. Denis, B. Connolly, K. M. Metters, and A. Giaid. 1999b. Immunolocalization of cyclooxygenase-2 in macula densa of human elderly. FEBS Lett. 457: 475-477.
18. Cravatt, B. F., K. Demarest, M. P. Patricelli, M. H. Bracey, D. K. Giang, B. R. Martin, and A. H. Lichtman. 2001. Supersenstivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA. 98: 9371-9376.
19. Giuffrida, A., F. Rodriguez de Fonseca, F. Nava, P. Loubet-Lescoulie, and D. Piomelli. 2000. Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur. J. Pharmacol. 408: 161-168.
20. Arai, Y., T. Fukushima, M. Shirao, X. Yang, and K. Imai. 2000. Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. Biomed. Chromatogr. 14: 118-124.
21. Matsuda, S., N. Kanemitsu, A. Nakamura, Y. Mimura, N. Ueda, Y. Kurahashi, and S. Yamamoto. 1997. Metabolism of anandamide, an endogenous cannabinoid receptor ligand in porcine ocular tissues. Exp. Eye Res. 64: 707-711.
22. 2α pharmacological characterization of a novel, naturally occurring substance (Abstract at Association for Research in Vision and Ophthalmology (ARVO) meeting. Ft. Lauderdale, FL, April 29-May 4, 2001).
23. Matias, I., J. Chen, L. DePetrocellis, T. Bisongno, A. Ligresti, F. Fezza, A. H-P. Krauss, L. Shi, C. E. Protzman, C. Li, Y. Liang, A. I. Nieves, K. M. Kedzie, R. M. Burke, V. Di Marzo, and D. Woodward. Prostamides: pharmacology and metabolism in vitro. J. Pharm. Exp. Ther. In press.
24. Ross, R. A., S. J. Craib, L. A. Stevenson, R. G. Pertwee, A. Henderson, J. Toole, and H. C. J. Ellington. 2002. Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther. 301: 900-907.